H20.823
Vogt-Koyanagi syndrome, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Vogt-Koyanagi syndrome is a rare, multisystem disorder that primarily affects the eyes, skin, and nervous system. When it is referred to as bilateral, it indicates that both eyes are involved. This condition involves inflammation of the melanocyte-containing tissues, which can lead to various symptoms affecting vision and other bodily functions. Understanding this syndrome helps in recognizing its importance and the need for appropriate medical management.
Causes & Symptoms
Clinical Causes: The exact cause is unknown, but it is believed to be an autoimmune response where the body's immune system attacks its own melanocytes. Genetic factors may play a role, as the condition has been observed more frequently in certain ethnic groups, such as those of Asian, Middle Eastern, and Latin American descent. Environmental factors are not well understood, but triggers might include infections that could initiate or exacerbate the immune response.
Key Symptoms: Visual disturbances, such as blurred vision, photophobia (sensitivity to light), or floaters. Darkening of the skin (hyperpigmentation) or skin depigmentation, especially around the eyes, face, or other areas. Headaches and neurological symptoms like dizziness, tinnitus (ringing in the ears), or nerve-related issues. Auditory problems, including hearing loss or tinnitus. Possible onset of vitiligo, an autoimmune skin condition that causes patches of skin to lose pigment. In some cases, meningoencephalitis symptoms, such as neck stiffness, confusion, or changes in consciousness, may occur.
Diagnostic & Treatment
Diagnosis Path: Ocular examinations with slit-lamp microscopy to assess intraocular inflammation. Fundus photography to document changes in the retina and choroid. Blood tests to evaluate inflammation markers and to rule out infections. Imaging studies like MRI scans can help identify neurological involvement. Skin biopsy might be performed if pigmentary changes are present, supporting the diagnosis of depigmentation.
Treatment Protocols: High-dose corticosteroids to reduce inflammation quickly and effectively. Immunosuppressive therapies such as azathioprine or cyclosporine may be used for long-term management. Monitoring and treating complications like glaucoma or cataracts that may arise due to inflammation. Addressing skin depigmentation with skin care and dermatological treatments, if necessary. Regular follow-up with ophthalmologists and other specialists to monitor disease progression and treatment response.
Clinical Advice & FAQs
Billing Guidance
Is H20.823 a billable ICD-10 code?
Yes, H20.823 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H20.823?
Clinical documentation must specify the nature of Vogt-Koyanagi syndrome, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference